KR880009964A - 아릴피페라지닐-에틸(또는 부틸)-페닐-헤테로시클릭 화합물 - Google Patents

아릴피페라지닐-에틸(또는 부틸)-페닐-헤테로시클릭 화합물 Download PDF

Info

Publication number
KR880009964A
KR880009964A KR1019880001454A KR880001454A KR880009964A KR 880009964 A KR880009964 A KR 880009964A KR 1019880001454 A KR1019880001454 A KR 1019880001454A KR 880001454 A KR880001454 A KR 880001454A KR 880009964 A KR880009964 A KR 880009964A
Authority
KR
South Korea
Prior art keywords
group
ring
atom
compound according
sulfur atom
Prior art date
Application number
KR1019880001454A
Other languages
English (en)
Other versions
KR900004126B1 (ko
Inventor
아담스 로우에 3세 존
Original Assignee
알렌 제이.스피겔
화이자 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알렌 제이.스피겔, 화이자 인코포레이티드 filed Critical 알렌 제이.스피겔
Publication of KR880009964A publication Critical patent/KR880009964A/ko
Application granted granted Critical
Publication of KR900004126B1 publication Critical patent/KR900004126B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

내용 없음.

Description

아릴피페라지닐-에틸(또는 부틸)-페닐-헤테로시클릭 화합물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. 하기 일반식으로 표시되는 화합물 또는 그의 제약상 허용되는 산 부가염.
    상기식중, Ar은 페닐 또는 3-트리플루오로메틸페닐기, 3-시아노피리딜기, 나프틸기, 또는 5- 또는 6-원 방향족 헤테로시클릭 고리이고, 이 고리는 1개의 질소, 산소 또는 황원자, 또는 2개의 질소(이중 1개는 산소 또는 황원자에 의해 치환될 수 있음)을 갖거나, 또는 이 고리는 벤조기와 축합되며, 상기 나프틸기, 헤테로시클릭 고리 또는 벤조헤테로시클릭 고리 각각은 1개의 플루오로, 클로로 또는 트리플루오로메틸기에 의해 임의로 치환될 수 있고, 상기 나프틸기 또는 벤조헤테로시클릭 고리의 경우에 있어서 치환은 피페라지닐기와 결합되지 않은 고리에서 행해지고, n은 2,3 또는 4이고, R은 수소원자 또는 (C1-C3)알킬기이고, X는 질소, 산소 또는 황원자이고, Z-Y는 C-H, C-OH, C-SH, C-NH2, C-(C1-C3)알킬, C-(C1-C3)알킬아미노기 또는 질소원자이고, 단 Z-Y가 질소원자일 경우, X는 산소원자가 아님.
  2. 제1항에 있어서, n이 2이고, R이 수소원자임을 특징으로 하는 화합물.
  3. 제1항 또는 제2항에 있어서, Ar이 나프틸기 또는 벤조기와 축합된 5- 또는 6-원 방향족 헤테로시클릭 고리임을 특징으로 하는 화합물.
  4. 제1항 내지 제 3항중 어느 하나의 항에 있어서, X가 황원자이고, Y가 아미노기임을 특징으로 하는 화합물.
  5. 정신 질환치료에 유효한 양의 제1항에 의한 화합물 및 제약상 허용되는 담체 또는 희석제로 되는 제약 조성물.
  6. 제5항에 있어서, n이 2이고, R이 수소원자임을 특징으로 하는 조성물.
  7. 제5항 또는 제6항에 있어서, Ar이 나프틸기 또는 벤조기와 축합된 5- 또는 6-원 방향족 헤테로시클릭 고리임을 특징으로 하는 조성물.
  8. 제5항 내지 제7항중 어느 하나의 항에 있어서, X가 황원자이고 Y가 아미노기임을 특징으로 하는 조성물.
  9. 정신 질환을 치료하기 위한 제1항에 의한 화합물.
    ※참고사항:최초출원 내용에 의하여 공개하는 것임.
KR1019880001454A 1987-02-17 1988-02-13 아릴피페라지닐-에틸(또는 부틸)-페닐-헤테로시클릭 화합물 KR900004126B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8700340 1987-02-17
USPCT/US87/00340 1987-02-17
US87/00340 1987-02-17

Publications (2)

Publication Number Publication Date
KR880009964A true KR880009964A (ko) 1988-10-06
KR900004126B1 KR900004126B1 (ko) 1990-06-16

Family

ID=22202287

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880001454A KR900004126B1 (ko) 1987-02-17 1988-02-13 아릴피페라지닐-에틸(또는 부틸)-페닐-헤테로시클릭 화합물

Country Status (30)

Country Link
EP (1) EP0279598B1 (ko)
JP (1) JPH0699405B2 (ko)
KR (1) KR900004126B1 (ko)
CN (1) CN1015627B (ko)
AP (1) AP88A (ko)
AR (1) AR245125A1 (ko)
AT (1) ATE94537T1 (ko)
AU (1) AU583761B2 (ko)
CA (1) CA1312080C (ko)
CS (1) CS272783B2 (ko)
DD (1) DD272080A5 (ko)
DE (1) DE3884007T2 (ko)
DK (1) DK170878B1 (ko)
EG (1) EG18635A (ko)
ES (1) ES2058249T3 (ko)
FI (1) FI91752C (ko)
HU (1) HU207731B (ko)
IE (1) IE61258B1 (ko)
IL (1) IL85368A0 (ko)
IN (1) IN171858B (ko)
MA (1) MA21183A1 (ko)
MX (1) MX174210B (ko)
MY (1) MY103210A (ko)
NO (1) NO170582C (ko)
NZ (1) NZ223530A (ko)
PL (1) PL157118B1 (ko)
PT (1) PT86766B (ko)
SU (1) SU1634136A3 (ko)
YU (1) YU46624B (ko)
ZA (1) ZA881064B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
SE8803429D0 (sv) * 1988-09-28 1988-09-28 Pharmacia Ab Novel pyridyl- and pyrimidyl derivatives
US5166157A (en) * 1989-12-20 1992-11-24 Adir Et Compagnie Naphthyl piperazines useful as 5-HT1A receptor ligands
US5166156A (en) * 1989-12-20 1992-11-24 Adir Et Compagnie Naphthyl piperazines useful as 5-HT1A receptor ligands
US5162324A (en) * 1989-12-20 1992-11-10 Adir Et Compagnie Naphyl piperazines useful as 5-HT1A receptor ligands
FR2655988B1 (fr) * 1989-12-20 1994-05-20 Adir Cie Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5162321A (en) * 1989-12-20 1992-11-10 Adir Et Compagnie 1-naphthyl piperazines useful as 5-HT1A receptor ligands
DE69611783T2 (de) * 1995-06-06 2001-09-20 Aventis Pharma Inc Benzisoxazol- und indazol- derivate als antipsychotika
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
WO1997024343A1 (en) 1995-12-29 1997-07-10 Boehringer Ingelheim Pharmaceuticals, Inc. Phenyl thiazole derivatives with anti herpes virus properties
US6288091B1 (en) 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
WO1999001420A1 (fr) 1997-07-03 1999-01-14 Taito Co., Ltd. Procede de preparation de derives d'acide 2-aminomalonique, et intermediaires utilises dans ce procede
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2927924A (en) * 1958-04-03 1960-03-08 Lilly Co Eli Novel phenethyl-substituted piperazines
FR1300728A (ko) * 1959-10-20 1962-07-02
DE1695410A1 (de) * 1967-04-20 1971-04-08 Merck Patent Gmbh Verfahren zur Herstellung von 1-(Thiazolyl-5-alkyl)-4-(pyridyl-2)-piperazinen
JPS5910675B2 (ja) * 1976-03-22 1984-03-10 ウェルファイド株式会社 アラルキルアミン誘導体
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4619930A (en) * 1985-01-16 1986-10-28 Bristol-Myers Company Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use
JPH075579B2 (ja) * 1986-09-01 1995-01-25 吉富製薬株式会社 アミノチアゾ−ル化合物

Also Published As

Publication number Publication date
DE3884007D1 (de) 1993-10-21
MX174210B (es) 1994-04-28
AP88A (en) 1990-06-06
AR245125A1 (es) 1993-12-30
CN1015627B (zh) 1992-02-26
IE61258B1 (en) 1994-10-19
YU46624B (sh) 1994-01-20
FI880716A (fi) 1988-08-18
CS272783B2 (en) 1991-02-12
AP8800082A0 (en) 1988-02-01
CN88100986A (zh) 1988-09-21
FI880716A0 (fi) 1988-02-16
CS96488A2 (en) 1990-04-11
EP0279598B1 (en) 1993-09-15
JPH0699405B2 (ja) 1994-12-07
HUT50334A (en) 1990-01-29
AU1174088A (en) 1988-08-18
KR900004126B1 (ko) 1990-06-16
MY103210A (en) 1993-05-29
IN171858B (ko) 1993-01-23
NZ223530A (en) 1990-07-26
SU1634136A3 (ru) 1991-03-07
DK78888A (da) 1988-08-18
NO880667D0 (no) 1988-02-16
CA1312080C (en) 1992-12-29
ZA881064B (en) 1989-09-27
ES2058249T3 (es) 1994-11-01
DK170878B1 (da) 1996-02-26
EP0279598A2 (en) 1988-08-24
YU30388A (en) 1989-10-31
JPS63216875A (ja) 1988-09-09
AU583761B2 (en) 1989-05-04
NO170582B (no) 1992-07-27
IE880420L (en) 1988-08-17
MX10428A (es) 1993-09-01
NO880667L (no) 1988-08-18
FI91752B (fi) 1994-04-29
MA21183A1 (fr) 1988-10-01
FI91752C (fi) 1994-08-10
DE3884007T2 (de) 1994-01-20
DK78888D0 (da) 1988-02-16
PL270653A1 (en) 1988-12-08
IL85368A0 (en) 1988-07-31
DD272080A5 (de) 1989-09-27
EP0279598A3 (en) 1989-07-26
ATE94537T1 (de) 1993-10-15
PL157118B1 (pl) 1992-04-30
EG18635A (en) 1994-04-30
PT86766A (pt) 1988-03-01
NO170582C (no) 1992-11-04
HU207731B (en) 1993-05-28
PT86766B (pt) 1992-05-29

Similar Documents

Publication Publication Date Title
DK0589924T3 (da) Fluoralkoxybenzylaminoderivater af nitrogenholdige heterocyclusser
KR880009964A (ko) 아릴피페라지닐-에틸(또는 부틸)-페닐-헤테로시클릭 화합물
KR960004344A (ko) 6원 질소 함유 헤테로아릴-옥사졸리디논
FI800047A (fi) Nya (piperidinylalkyl)kinazolinderivat
FI941212A0 (fi) Fuusioituneet trisykliset, typpeä sisältävät heterosykliset yhdisteet
ES2188280T3 (es) Acetales heteroaril-ciclicos.
KR910016697A (ko) 테트라히드로피리딘 유도체
ATE14439T1 (de) Veraenderte d-retro cyclische hexapeptide, analoge von somatostatin, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
KR920014810A (ko) 항균제
DE69408962D1 (de) Naphthalen-Derivate mit Affinität für Melatonin-Rezeptoren, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
FI823897L (fi) Heterocykliska foereningar
ES8701158A1 (es) Procedimiento para la obtencion de compuestos carbonilicos
KR920006350A (ko) 3-아릴-4(3h)퀴나졸리논 cck 길항물질 및 그의 약학 조성물
KR880012590A (ko) 신규 함질소 화합물
KR920016448A (ko) 피페리딘 유도체
SE8503415L (sv) Nya isoindolinylalkylpiperaziner och farmaceutiska kompositioner innehallande desamma
KR920701120A (ko) 치환된 비시클로헵탄디온 유도체
KR920014818A (ko) 항균제
ES455909A1 (es) Procedimiento para preparar derivados de piperacina.
KR910015537A (ko) 신규 1-아릴술포닐-2-피페리디논 유도체, 이의 제조방법, 제조용 중간체, 의약품으로서의 용도 및 이 화합물을 함유하는 조성물
TNSN86161A1 (fr) Nouvelles anthracyclines et medicaments les contenant
ES381036A1 (es) Medicamentos analgesicos a base de n-(aroilalkil) n'-(alfa-nols) piperacinas y sus derivados, y procedimiento para su obtencion.
ES407816A1 (es) Metodo para producir derivados de benzodiazepina.
ATE56442T1 (de) 2,6-piperazin-dion-derivate, ihre verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
KR830005188A (ko) 혈당강하성 구아닐 아미딘의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20030417

Year of fee payment: 14

LAPS Lapse due to unpaid annual fee